Name | Value |
---|---|
Revenues | 166.7M |
Cost of Revenue | 31.4M |
Gross Profit | 135.3M |
Operating Expense | 153.3M |
Operating I/L | -7.4M |
Other Income/Expense | 1.1M |
Interest Income | 0.0M |
Pretax | -6.3M |
Income Tax Expense | 3.1M |
Net Income/Loss | -9.4M |
Abcam plc is a life science company specializing in the development and distribution of reagents and tools for scientific research, diagnostics, and drug discovery. Its product portfolio includes primary and secondary antibodies, conjugated antibodies and kits, immunoassays, proteins, peptides, edited cell lines, lysates, cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company caters to scientists and researchers in academic institutions, research institutes, pharmaceutical, biotechnology, and diagnostics companies. Abcam plc operates globally, serving customers in the Americas, Europe, the Middle East, Africa, China, Japan, and the rest of the Asia Pacific. The company primarily generates revenue through the online sale of its products.